Keyphrases
18 Years Old
9%
Allogeneic Hematopoietic Cell Transplant Recipients
9%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
100%
Clinical Outcomes
100%
Confidence Interval
45%
Corticosteroids
9%
Cumulative Incidence
9%
Disease Treatment
9%
Graft-versus-host Disease (GvHD)
100%
Group-based
9%
Hazard Ratio
18%
High Risk
18%
Minnesota
9%
Mortality Hazard
18%
Non-relapse Mortality
18%
Odds Ratio
27%
Old Age
9%
Overall Mortality
9%
Overall Survival
9%
Pediatric
9%
Response Group
9%
Risk Factors
100%
Risk Outcomes
9%
Sensitive Groups
9%
Steroid Resistance
54%
Steroid Use
100%
Steroid-sensitive
63%
Treatment Response
9%
Unrelated Donor
9%
Medicine and Dentistry
Acute Graft Versus Host Disease
100%
Cell Transplantation
100%
Combination Therapy
11%
Cumulative Incidence
11%
Graft Versus Host Reaction
33%
Hazard Ratio
22%
Hematopoietic Cell
100%
Odds Ratio
33%
Overall Survival
11%
Pediatrics
11%
Transplantation
11%
Treatment Response
11%
Immunology and Microbiology
Acute Graft Versus Host Disease
100%
Cell Transplantation
100%
Graft-Versus-Host Disease
33%
Hematopoietic Cell
100%
Overall Survival
11%
Biochemistry, Genetics and Molecular Biology
Cell Transplantation
100%
Hematopoietic Cell
100%
Host
100%
Overall Survival
11%
Mathematics
Confidence Interval
100%
Dependent Group
20%
Hazard Ratio
40%
Odds Ratio
60%
Sensitive Group
20%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Graft Versus Host Disease
100%
Combination Therapy
11%
Graft Versus Host Reaction
33%
Overall Survival
11%